News
Agios’s pyruvate kinase deficiency treatment receives FDA orphan drug designation
Agios Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) for its investigational medicine AG-348 to treat pyruvate kinase...
Press Releases
Micromeritics Introduces Cloud-based MicroActive Share
Micromeritics has announced the release of MicroActive Share, a cloud-based infrastructure in its product portfolio. The infrastructure provides a new platform...
Press Releases
UCB Wins Customer Innovation and Lifetime Value Achievement Awards for Improving Patient Experience
Two of UCB's biggest patient innovators were announced as winners at the eyeforpharma Barcelona Awards for their long-term commitment to improve patient experiences. ...
Press Releases
Janssen Healthcare Innovation’s Care4Today Wins Two Awards at the eyeforpharma Barcelona Awards 2015
Two initiatives from Janssen Healthcare Innovation were voted 'Most Valuable' at the eyeforpharma Barcelona Awards, which is the first time a single company has...
Press Releases
Sanofi Pasteur Wins Most Impactful Emerging or Global Initiative for Commitment to Fighting Dengue Fever
Sanofi Pasteur's global awareness programme for dengue fever, Break Dengue, was announced the winner of the Most Impactful Emerging or Global Initiative award at...
News
GSK and CSHL to develop new treatment for obesity and type 2 diabetes
The partnership will identify potent, selective and orally bioavailable small molecules that inhibit PTP1B activity in-vivo following stimulation by insulin and leptin to overcome...
News
Takeda and ImmunoGen partner to develop anti-cancer therapeutics
Japanese drug maker Takeda Pharmaceutical Company, through its wholly owned subsidiary Millennium Pharmaceuticals, has signed an agreement with US-based ImmunoGen to develop and commercialise...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read